Jingwei Chi
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
- Parkinson's Disease Mechanisms and Treatments
Papers in
-
- Mitochondrial Function and Pathology 4
-
- Gout, Hyperuricemia, Uric Acid 5
- Co-authors
- Yangang Wang (21 shared papers)Wenshan Lv (7 shared papers)Yue Zhou (5 shared papers)Bingzi Dong (7 shared papers)Ramesh Raliya (1 shared paper)Liyan Shen (1 shared paper)Qing Yang (1 shared paper)Qian Pan (3 shared papers)
- Journals
- PLoS ONE (4 papers)Frontiers in Endocrinology (4 papers)Biochemical and Biophysical Research Communications (3 papers)Journal of Diabetes (2 papers)International Journal of Infectious Diseases (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Jingwei Chi
49 papers receiving 1.4k citations
Jingwei Chi's Hit Papers
Peers
Comparison fields: 5 of 123
- Infectious Diseases 283
- Neurology 183
- Nephrology 65
- Geriatrics and Gerontology 30
- Endocrinology, Diabetes and Metabolism 100
Countries citing papers authored by Jingwei Chi
This map shows the geographic impact of Jingwei Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingwei Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingwei Chi more than expected).
Fields of papers citing papers by Jingwei Chi
This network shows the impact of papers produced by Jingwei Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingwei Chi. The network helps show where Jingwei Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingwei Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 ( Hit paper breakdown → | 2020 | 335 |
| 2 | 2020 | 273 | |
| 3 | 2013 | 127 | |
| 4 | 2011 | 118 | |
| 5 | 2017 | 45 | |
| 6 | 2012 | 42 | |
| 7 | 2020 | 40 | |
| 8 | 2013 | 40 | |
| 9 | 2021 | 37 | |
| 10 | 2013 | 36 | |
| 11 | 2018 | 29 | |
| 12 | 2019 | 27 | |
| 13 | 2020 | 25 | |
| 14 | 2022 | 23 | |
| 15 | 2023 | 22 | |
| 16 | 2016 | 20 | |
| 17 | 2020 | 18 | |
| 18 | 2017 | 18 | |
| 19 | 2023 | 16 | |
| 20 | 2018 | 15 |
About Jingwei Chi
Jingwei Chi is a scholar working on Molecular Biology, Nephrology, Cardiology and Cardiovascular Medicine, Surgery and Epidemiology, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (5 papers), Lipid metabolism and disorders (5 papers), Autophagy in Disease and Therapy (4 papers), Mitochondrial Function and Pathology (4 papers), Diabetes and associated disorders (3 papers), Mesenchymal stem cell research (3 papers), Pancreatic function and diabetes (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Infectious Diseases (283 citations), Neurology (183 citations), Nephrology (65 citations), Geriatrics and Gerontology (30 citations) and Endocrinology, Diabetes and Metabolism (100 citations). Jingwei Chi has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Yangang Wang, Wenshan Lv, Yue Zhou, Bingzi Dong, Ramesh Raliya, Liyan Shen, Qing Yang, Qian Pan, Danling Wang and Zhuohua Zhang. Their work appears in journals such as PLoS ONE, Frontiers in Endocrinology, Biochemical and Biophysical Research Communications, Journal of Diabetes and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.